Technology
Health
Biotechnology

Novavax

$6.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
-$0.07 (-1.14%) After Hours

Why Robinhood?

You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!

About

Novavax, Inc. Common Stock, also called Novavax, is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Employees
379
Headquarters
Gaithersburg, Maryland
Founded
1987
Market Cap
143.65M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
525.37K
High Today
$6.16
Low Today
$5.92
Open Price
$6.14
Volume
279.81K
52 Week High
$51.60
52 Week Low
$5.72

Collections

Technology
Health
Biotechnology
US
North America

News

BenzingaMay 17

Eltek Ltd., Novavax, Inc. - Learning When To Pick Your Battles Starts With Winning Setups

Good news and bad news this week. Despite May putting in some solid days of trading, I unfortunately had my first daily loss for the month, and it was a fairly big one at over $6,000. Still, May has been a good trading month in spite of some persistent chop. I’m up about $50,000 over the first half of May and, despite the mid-sized red day I saw on Tuesday, this is likely to be another green week if I can stay positive on Friday. However, my winning trades for the week were still hard-fought. My biggest w...

4,277
Yahoo FinanceMay 16

Are These 2 Beaten-Down Biotech Stocks Worth the Risk?

Catalyst Pharmaceuticals (NASDAQ: CPRX) and Novavax (NASDAQ: NVAX) have both had an absolutely terrible May so far. Each company has shed a significant chunk of its value in just the first two weeks of the month. Beaten-down biopharma stocks, though, can recover in the blink of an eye. Should bargain hunters flock to these two names with the hope of a quick recovery? Let's examine what's driving their stories to find out. A white man with curly hair and glasses getting punched in the face. Scroll to cont...

5,229
Seeking AlphaMay 14

Bargain hunters jump into Novavax, up 28%

The dramatic selloff in Novavax (NVAX +27.8% ), shares had lost 88% of their value since early February before today's action, appears to have reached an attractive level for bargain hunters.

6,011

Earnings

-$0.16
-$0.14
-$0.13
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.